Navigation Links
First-Quarter 2008 Results Teleconference/Webcast for VNUS Medical Technologies Interrupted Due to Technical Difficulties
Date:4/22/2008

SAN JOSE, Calif., April 22 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, explains interruption of its first-quarter 2008 teleconference and webcast held yesterday at 2:00 p.m. PT/5:00 p.m./ET. As a result of teleconference vendor communications difficulties, the Question-and-Answer period did not take place as planned.

Interested parties are encouraged to review the company's news release on its first-quarter 2008 financial results and to listen to either the telephonic replay (719-457-0820, code number 4678111) or audio webcast of the prepared remarks by management archived on the company's website at http://ir.vnus.com/. If anyone has questions, they're invited to contact the company at ir@vnus.com.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated to date with VNUS Closure catheters. For more information, please visit the corporate website at http://www.vnus.com .


'/>"/>
SOURCE VNUS Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast
2. Cynosure to Announce First-Quarter 2008 Financial Results on April 29
3. VNUS Medical Technologies to Report First-Quarter 2008 Results and Webcast Teleconference on April 21
4. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
5. Abbott Hosts Conference Call for First-Quarter Earnings
6. Cardinal Health To Announce First-Quarter Results on November 5
7. Quality Care, Not Number of Procedures, Determines Bypass Results
8. Allscripts to Announce First Quarter 2008 Results on April 30
9. CuraGen Reports First Quarter 2008 Financial Results
10. Albemarle Reports Record Quarterly Net Sales and Operating Results
11. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 2017 , ... Salveo for life, a company that distributes an effervescent lime-flavored ... States as part of its presence to expand its market reach. , Using a ... productions of nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Seamild, the ... on the futuristic vision of its owner and founder. As Oat is recognized globally ... to everybody he knows personally as he believes it is a move to sow ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... of Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual ... alumni, family, friends, and community. “Coming Home 2017” will be held on ...
(Date:1/21/2017)... Santa Rosa, CA (PRWEB) , ... January 21, ... ... announce the opening of its new medical office in Petaluma, located at 167 ... full-service casting room, access to SRO sports medicine and rehabilitation services ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Texas Periodontist Dr. Dan Holtzclaw in media for its creos™ line of bone ... performed by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology: